“Early data arising from our patients dosed at low levels with our CF33 oncolytic virus have indicated immune activation is occurring in the tumour microenvironment, turning the tumour from ‘immunologically cold to hot’. This is a perfect time to introduce an immune checkpoint inhibitor such as pembrolizumab.”
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene VAXINIA trial advances to Combination Cohort
Ann: Imugene VAXINIA trial advances to Combination Cohort, page-10
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $401.6M |
Open | High | Low | Value | Volume |
5.6¢ | 5.7¢ | 5.4¢ | $1.182M | 21.47M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 3441484 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 574188 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 3376484 | 0.054 |
23 | 3548958 | 0.053 |
32 | 5485649 | 0.052 |
32 | 3762117 | 0.051 |
73 | 6843215 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 574188 | 6 |
0.056 | 1053287 | 5 |
0.057 | 1397057 | 10 |
0.058 | 682062 | 3 |
0.059 | 350000 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |